Project Grant RF1NS128145
Award Date
9/15/22
Completion Date
8/31/25
Dollars Obligated
$4M
Funding Federal Agency
National Institute on Aging
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
This $107,948 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to enhance understanding of the biological signatures that distinguish subgroups of patients with Alzheimer's disease (AD). The key goals are to: Determine if AD subtypes can be identified solely using magnetic resonance imaging (MRI)-derived features through the application of machine learning algorithms. Integrate epigenetic profiles, including small non-coding RNA expression and DNA...
This federal Project Grant award of $802,034 from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) will fund a multimodal, multiscale, and multistage systems biology (M3SB) infrastructure to advance precision medicine for Alzheimer's disease (AD) and longevity. The project aims to: 1) conduct multi-omic analyses to identify bioage-modifying targets and repurposable medicines for AD/ADRD; 2) build inflammatory aging (iAge) and phenoAge clocks using longitudinal...
This $6.18 million project grant from the National Institutes of Health's National Institute on Aging will fund the University of Texas at Austin to conduct the first large-scale genomic analysis of continuous rates of longitudinal aging-related cognitive change prior to dementia onset. Working with sub-awardees the University of Colorado and the University of Edinburgh, the researchers will identify genetic variants beyond APOE that confer risk for cognitive decline leading to eventual...
This $287,118 Project Grant was awarded on September 1, 2023 by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) grant program. The grant will fund the development of techniques to use deep transfer learning and multimodal data, including brain MRIs, genetic information, and cognitive tests, to enable the early detection and forecasting of Alzheimer's disease progression. The University of Massachusetts (UMass), as the prime awardee, will create an end-to-end...
This federal Project Grant award of $307,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to conduct a single, highly powered study to identify memory processes that are most sensitive to the asymptomatic, preclinical stage of Alzheimer's disease (AD) pathology. The study combines a continuous report item-location associative memory task with advanced behavioral and neural modeling to estimate subtle changes in memory precision that may differentiate healthy...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Transchromix LLC for $994,436 supports the development of a novel, brain-penetrant drug targeting the histone methyltransferase G9A for the treatment of Alzheimer's disease. The project aims to elucidate the mechanism of action for the drug candidate MS1262, which has been shown to reverse Alzheimer's-related protein expression and restore cognitive and affective functions in a mouse model....
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $419,005 to Purdue University to study the epigenome-metabolism nexus as a driver of circadian disruption in Alzheimer's disease. The research aims to determine how Alzheimer's-associated tau protein alters circadian gene expression, one-carbon metabolism, and histone methylation in a genetically tractable Drosophila (fruit fly) model system. The project will focus on the roles of the enzymes...
This $745,092 Project Grant was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to the Rector & Visitors of the University of Virginia (UVA) to conduct research on the epitranscriptomic mechanisms underlying the pathogenesis of Alzheimer's disease (AD) and related tauopathies. The key goals of the project are to: 1) Decode the epitranscriptomic profiles impacted by tau pathology using m6A DART-seq, 2) Determine the role of RNA methylation in AD pathogenesis using 3D...
This $4,260,300 project grant from the National Institutes of Health's National Institute on Aging will fund research under the Aging Research program (CFDA 93.866) to investigate the association between in utero environmental exposures and life-course cognition and prodromal Alzheimer's disease in midlife. The Public Health Institute will leverage existing data and biospecimens from the 50+ year follow up of the Child Health and Development Studies birth cohort to conduct targeted and...
This Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), provides $2,251,070 to the University of California Irvine through July 2025. The grant supports research to develop new statistical methodologies for analyzing Alzheimer's disease data from longitudinal cohort studies. Key deliverables include methods for assessing prediction precision for recurrent event survival data using time-dependent ROC and C-index...